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Background: Encephalomyocarditis virus (EMCV) can cause myocarditis, respiratory failure, reproductive failure, and
sudden death in pre-weaned piglets, which has been isolated in China. EMCV VP1 protein was one of the most
important structural proteins and played an important role in the protective immunity. In this study, 10 monoclonal
antibodies (McAbs) against EMCV VP1 were screened and identified.
Results: Epitope mapping results indicated that McAbs (6E11, 7A7, 7C9) specifically recognized the linear epitopes
V(2)ENAEK(7), McAbs (1D1, 2A2, 5A1, 5A11, 5G1) recognized the epitope F(19)VAQPVY(25), and McAbs 1G8 and 3A9
recognized P(42)IGAFTVK(49). Protein sequence alignment of VP1 with 16 EMCV isolates indicated that the epitope
F(19)VAQPVY(25) was conserved in all the reference strains. The epitopes P(42)IGAFTVK(49) and V(2)ENAEK(7) only
had 1 or 2 variable amino acid among the reference strains. The 3D model analysis results showed that these
epitopes presented as spheres were shown within the context of the complete particle.
Conclusions: In this study, ten McAbs against EMCV VP1 were developed and three B-cells epitopes (2-7aa, 19-25aa
and 42-49aa) were defined in VP1. All the results herein will promote the future investigations into the function of
VP1 of EMCV and development of diagnostic methods of EMCV.
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Encephalomyocarditis virus (EMCV) is characterized by
not only myocarditis and encephalitis, but also neuro-
logical diseases, reproductive disorders and diabetes in
many mammalian species [1-8]. Rodents are considered
to be natural hosts of EMCV and are thought to be the
primary reservoir and disseminators of the virus. Out of
all domestic animals, pigs are the most susceptible to
EMCV infection, which can cause severe economic losses
on pig production due to high mortality in piglets as a re-
sult of respiratory failure [2,9,10] and in sows as a result of
myocarditis and reproductive failure [11-13].
EMCV is a member of the Cardiovirus genus of Picorna-
viridae [14] and has a single-stranded positive-sense RNA
of approximately 7.8 kb [15]. The ORF encodes for a poly-
protein that comprises both non-structural and structural* Correspondence: jiangp@njau.edu.cn
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unless otherwise stated.elements divided into three primary precursor molecules,
namely P1, P2 and P3, encoding for 11 distinct proteins.
The structural proteins VP4, VP2, VP3 and VP1 make up
the viral capsid and are encoded in the P1 region towards
the 5′-end of the genome. The viral capsid proteins, in
their capacity to interact with cellular receptors, are
crucial for this entry step and may be considered to be
factors that can modulate EMCV virulence [1]. The
three major capsid proteins, VP1, VP2 and VP3 that
constitute the external virion shell of picornaviruses, are
considered to play a pivotal role in viral infection and
host recognition [16]. Among them, VP1 is one of the
most antigenic and can stimulate the organism to pro-
duce neutralization antibody [17,18].
The detailed analysis of epitopes is important for the
understanding of immunological events and for the de-
velopment of epitope-based marker vaccines and diag-
nostic tools for various diseases [19-21]. In this paper,
VP1 protein of EMCV NJ08 strain was expressed by the
Escherichia coli system and ten monoclonal antibodies
(McAbs) against the recombinant EMCV VP1 were
screened and identified. Three linear epitopes (2-7aa,s is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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EMCV.
Results
Development of monoclonal antibodies against VP1 protein
After screening of the fusion cells by indirect ELISA, the
positive hybridoma cells secreting the antibodies against
VP1 protein were selected and sub-cloned thrice by limit-
ing dilution, and ten McAbs were generated and named as
1D1, 1 F3, 1G8, 1D1, 2A2, 5A1, 5A11, 5G1, 6E11, 7A7
and 7C9. The results of Western blot showed that these
McAbs were all directed against the purified EMCV and
rVP1 protein expressed in E. Coli (Figure 1). Meanwhile,
IFA results also showed that these McAbs could react with
the EMCV in BHK21 cells (Figure 1). The titres of anti-
bodies in the cells cultures were 1:1600–3200.
Expression and identification of the truncated fragments
Twenty-six overlapping VP1 protein gene fragments were
prepared by PCR and cloned into a GST fusion protein ex-
pression vector. After validation by restriction analysis and
nucleotide sequencing, recombinant proteins encoded by
each of these constructs were expressed in E.coli. The
resulting recombinant proteins were identified using
Western blot with GST-tagged monoclonal antibody.
The results showed that all the proteins were reactive
with GST-tagged McAb (Figure 2).
Mapping of the epitopes in VP1
In order to map the minimal sequences of the epitopes
recognized by McAbs, the series of truncated recombin-
ant proteins were used in Western blot was to identify
the reactivity of each of 10 anti-VP1 McAbs. The results
showed that McAbs (6E11, 7A7 and 7C9) could reacted
with fragments (F11, F9 and F3) containing the six
amino acids V(2)ENAEK(7), but not reacted with the
fragments with the deletion of any one of the six aminoFigure 1 Identification of McAbs with Western blot (up) and IFA (dow
Lane2. BHK21 cells lyses; Lane3. recombinant VP1 expressed in E. coli BL21acids (F10, F7 and F8). It indicated that amino acids V(2)
ENAEK(7) in VP1 were essential for this epitope
(Figure 3A). In the same way, McAbs (1D1, 2A2, 5A1,
5A11 and 5G1) reacted against the epitope comprising F
(19)VAQPVY(25), because they could react with the
fragments F15, F13, F18 and F19, but not F12, F16 and
F17 (Figure 3B). McAbs (1G8 and 3A9) could reacted
with fragments (F25, F26, F21 and F22) containing the
eight amino acids P(42)IGAFTVK(49), but not reacted
with the fragments with the deletion of any one of the
eight amino acids (F24, F23 and F20) (Figure 3C).
Meanwhile, those purified truncated fragment proteins
were used as the antigens in ELISA to detect the levels
of those McAbs. The results showed that the OD450
values of McAbs (6E11, 7A7 and 7C9) in F1, F3, F9 and
F11 groups were significantly higher than those in F6,
F7, F8 and F10 (p < 0.01) (Figure 4A). The OD450 values
of McAbs (1D1, 2A2, 5A1, 5A11 and 5G1) in F1, F13,
F14, F15, F18 and F19 groups were markedly higher than
those in F12, F16 and F17 groups (p < 0.05) (Figure 4B).
The levels of McAbs (1G8 and 3A9) in the groups of
F21, F22, F25 and F26 were notablely higher than those
in F20, F23 and F24 (p < 0.01) (Figure 4C).
Confirmation of the epitopes by using peptide-based ELISA
The synthetic peptides (P2-7aa, P19-25aa and P42-49aa),
purified rVP1 and GST-1-72aa (F3) proteins were used
as ELISA antigens. The results showed that OD450 values
of 6E11, 7A7 and 7C9 reacted with P2-7aa was highest
in those McAbs. And the levels of McAbs (1D1, 2A2,
5A1, 5A11 and 5G1) reacted with P19-25aa were obvi-
ously higher than those of other McAbs (P < 0.05).
McAbs 1G8 and 3A9 reacted with P42-49aa were signifi-
cantly higher than other McAbs (P < 0.05). It indicated
that the synthetic peptides P2-7aa, P19-25aa and P42-
49aa have immune reactivity with the pepide specific
McAbs, respectively (Figure 5).n). A. 1D1; B. 2A2; C. 6B11; D. 1G8. Western blot: Lane1. purified EMCV;
containing pET-28a-VP1 plasmid.
Figure 2 The truncated fragments F1 ~ F26 were identified by Western blot with GST-tagged monoclonal antibody.
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were relatively lower than those of McAbs reacted with
P2-7aa, P19-25aa and P42-49aa. It suggested that these
synthetic peptides reacted weakly with EMCV-specific
serum by peptide-based ELISA (Figure 5).Amino acid differences of the identified epitopes in
different EMCV strains
Alignment of the amino acid sequences of the different
EMCV isolates revealed that the minimal epitope F(19)
VAQPVY(25) was highly conserved among all the refer-
ence EMCV strains, the epitope V(2)ENAEK(7) was
relatively conserved among all EMCV strains, except for
a K7→ R7 change in GXLC, D variant, EMC-B and
EMC-D strains. In addition, the epitope P(42)IGAFTVK
(49) was conserved among the strains isolated from
China. Whereas there were variable amino acids in
different site of this region among the reference strains
isolated from other countries (Figure 6).3D model analysis of the three epitopes
There existed a very close structural analog to NJ08 in 2
structures published in 1990 and 1994 with PDB acces-
sion numbers 2MEV and 1MEC respectively both for
the mengo virus. The VP1 protein of NJ08 had very few
amino acid changes and no deletions or additions in the
sequence compared to the mengo virus VP1 sequence as
shown in Figure 7. Therefore any of the 2 structures
could be used a 3D model to map the epitopes within
the context of the complete viral particle. As show in
Figure 8, the 3 epitopes presented as spheres were
shown within the context of the complete particle with
colors of red for VP1, green for VP3, yellow for VP2 and
blue for VP4. The epitopes V(2)ENAEK(7) and F(19)
VAQPVY(25) shown as cyan and magenta spheres were
partially buried in the viron. P(42)IGAFTVK(49) shownas orange spheres was located circa the 5-fold icosahe-
dral axis of symmetry and was on the surface.
Discussion
B cell epitopes are linear or conformational resulting
from unique protein folding. They could be defined as
regions on the surface of the native antigen that could
bind to B-cell receptors or specific antibodies [21,23-25].
In this study, ten monoclonal antibodies (McAbs) against
the VP1 of EMCV were prepared by inoculated with the
purified killed EMCV, and then three minimal epitopes [V
(2)ENAEK(7), F(19)VAQPVY(25), and P(42)IGAFTVK
(49)] were identified in N terminus of the EMCV VP1,
using these McAbs and a series of recombinant truncated
VP1.
VP1 is one of the most important structures proteins
of EMCV, which can stimulate the organism to produce
neutralization antibody [18]. Immunization of mice with
recombinant VP1 protein (plasmids or recombinant ade-
noviruses expressing small hairpin RNAs targeted to
VP1 protein genes of EMCV), which could provide pro-
tective efficacy against EMCV [26,27]. DNA vaccines en-
coding an EMCV-D VP1 antigen confer protective
immunity against heterologous challenge with EMCV-K,
indicating that VP1 is a potential vaccine candidate for
controlling EMCV infection [28]. Thus it is need to ex-
plore the epitopes related to the protection or diagnosis
of this disease, even thought the residue at position 49,
62 and 100 are related to neutralization epitopes. In this
study, the ten anti-VP1 McAbs all did not have the abil-
ity to neutralize the EMCV in cells cultures (data not
shown here). However, they all could react with the
EMCV antigen in Western blot and IFA and could be
used for diagnosis of this virus.
Sequence analysis of both variants revealed one amino
acid exchange within the capsid protein VP1, demon-
strated that the diabetogenic and non-diabetogenic EMCV
Figure 3 Epitope mapping of McAbs by Western blot. The truncated fragments were detected with McAbs. (A) McAb 6B11 specifically
reacted with proteins which containing V(2)ENAEK(7) sequence; McAbs 7A7 and 7C9 have the same characteristic as 6E11(data not shown);
(B) McAb 1D1 specifically reacted with proteins which containing F(19)VAQPVY(25) sequence; McAbs 2A2, 4B9, 4 F1, 5A1, 5A11 and 5G1 have the
same characteristic as 1D1(data not shown); (C) McAb 3A9 specifically reacted with proteins which containing P(42)IGAFTVK(49) sequence; McAb
1G8 has the same characteristic as 3A9(data not shown).
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Studies of Theiler’s murine encephalomyelitis virus
(TMEV) demonstrated that the amino acids on the loops
exposed to the surface of the virion were important dis-
ease determinants [33]. The residue 49 was located in the
loop connecting the βB and βC strands of VP1, which wasexposed at the surface of the capsid and was known to be
part of a neutralization epitope [34]. In this study, the re-
sults of alignment of the amino acid sequences of different
EMCV isolates revealed that the epitope F(19)VAQPVY
(25) was highly conserved among all the reference EMCV
strains. There were only 1 or 2 amino acid residue
Figure 4 Reactivity of McAbs with the different fragments of VP1 expressed in E. coli by ELISA. (A) Reactivity of McAbs, 6E11, 7A7 and
7C9 with the fragments for identifying the epitope 2-7aa. (B) Reactivity of McAbs, 1D1, 2A2, 5A1, 5A11 and 5G1 with the fragments for identifying
the epitope 19-25aa. (C) Reactivity of McAbs, 1G8 and 3A9 with the fragments for identifying the epitope 42-49aa.
Figure 5 Reactivity of the peptides with each McAbs and EMCV-specific serum. The synthetic peptides, P2-7aa, P19-25aa and P42-49aa,
were used as ELISA antigens. The recombinant VP1 and F3 fragment of VP1 expressed in E.coli was used as positive control. P: EMCV-specific
serum; N: EMCV negative serum.
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Figure 6 Multiple alignments of the epitopes of VP1 among 16 EMCV isolates. The amino acid sequences of the immunodominant
epitopes identified were the gray area. Alignments of the amino acid sequences were made using DNAstar MegAlign software.
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ENAEK(7) between those strains. According to the model
of mengo virus, the 3D model of VP1 of EMCV was also
analyzed. In the picture, P(42)IGAFTVK(49) shown as or-
ange spheres was located circa the 5-fold icosahedral axis
of symmetry and was on the surface. Meanwhile, V(2)Figure 7 Alignment of whole VP1 amino acid sequence of NJ08 with
different amino acids.ENAEK(7) and F(19)VAQPVY(25) were at the N-terminus
and located *under* the VP3 protein and sandwiched with
the VP4 protein inside the particle. The obtain of the
Mc-Abs against these two epitopes in this study might
be explanted by the “breathing” of the N-terminal tail
between the VP3 and VP2 proteins. These two epitopesthe selected strain mengo virus. The black points represented
Figure 8 The locations of the three epitopes. The picture was
about the complete particle of mengo virus. VP1 is shown in red
ribbon, VP3 is shown in green ribbon, VP2 is shown in yellow
ribbon, and VP4 is shown in blue ribbon. The 3 epitopes presented
as spheres, V(2)ENAEK(7) is colored cyan, F(19)VAQPVY(25) is colored
magenta, and P(42)IGAFTVK(49) is orange. The figure was generated
using UCSF chimera [22]. (For interpretation of the references to
color in this figure legend, the reader is referred to the web version
of this article).
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results of alignment that these two regions were highly
conserved among all the reference EMCV strains.Conclusions
Here, ten McAbs against EMCV VP1 were developed
and three B-cells epitopes (2-7aa, 19-25aa and 42-49aa)
were defined in VP1. The results may contribute to
understand the antigenic structure of VP1 protein deeply
and facilitate the development of diagnostic method of
EMCV.Materials and methods
Virus, cells, animals and other reagents
EMCV isolate NJ08 (GenBank Accession No. HM641897)
used in this study was isolated and kept in our lab (Sub-
mitted 10-JUL-2010). BHK-21 cells were kept in Dulbec-
co’s Modified Eagle Medium supplemented with 10% fetal
bovine serum. The SP2/0 cells were grown in RPMI 1640
Medium supplemented with 20% fetal bovine serum.
Female BALB/c mice, 4–6 weeks of age, were purchased
from the Laboratory Animal Centre of Nantong Univer-
sity. HAT and HT Media Supplement (50×) were pur-
chased from Sigma. Horseradish peroxidase (HRP)-tagged
goat anti-mouse IgG was purchased from Wuhan Boster
Biological Technology Co. Rapid ELISA Mouse McAb
Isotyping Kit was purchased from Pierce.Expression and purification of recombinant VP1 protein
in E.coli and the purification of EMCV
The VP1 gene was amplified by PCR using the specific
primers kept in our lab. PCR products were digested by
BamH I and EcoR I, and cloned into prokaryotic expres-
sion vector pET-28a(+) subsequently. The recombinant
plasmids were verified by analysis and nucleotide se-
quencing, and then transformed into E.coli BL21 cells
for fusion proteins expression. The transformants were
cultured at 37°C in Luria-Bertani broth containing
0.05 mg/mL kanamycin until the optical density at
600 nm (OD600) reached 0.8. The cells were incubated
for another 4 h in the presence of 1.0 mM isopropyl-β-
D-thiogalactoside and harvested by centrifugation. The
E. coli/pET-28a-VP1 transformants were lysed by sonic-
ation, and then centrifuged at 3000 g for 15 min at 4°C.
The proteins were purified by ProBondTM Purification
System, according to the manufacturer’s instructions
(Invitrogen). The purified recombinant VP1 (rVP1) pro-
tein was detected by SDS-PAGE and Western blot, and
the concentration was determined by NANODROP 2000
Spectrophotometer (Thermo).
EMCV was sedimented and purified from the culture
medium with PEG-6000 by ultracentrifugation. The puri-
fied EMCV were analyzed by SDS-PAGE and Western
blot with anti-EMCV sera.
Development of monoclonal antibodies (McAbs)
The McAbs were developed and obtained as follows.
Briefly, inactivated EMCV was combined with equal vol-
umes of complete/incomplete Freund’s adjuvant (Sigma-
Aldrich) at final concentration of 0.2 mg/ml. Each fe-
male BALB/c mice (6-week-old) was immunized with
0.1 mg emulsion at 3 weeks intervals for 9 weeks. Three
days after the last injection, the spleens were surgically
removed from the mice and fused with Mouse myeloma
cells (SP2/0) using 50% (v/v) PEG. The fused hybridoma
clones were screened by the indirect ELISA for McAbs
that have strong reactivity with the rVP1 but not His
protein or bound EMCV but not BHK-21 cells’ protein.
Selected clones were subcloned by limiting dilution. As-
cites fluids were induced in pristine-primed BALB/c
mice. Finally, the McAbs were identified by Western blot
and indirect immunofluorescence assay (IFA).
Indirect ELISA
For screening the McAbs, ELISA plates were coated with
the purified rVP1 protein and E.coli/pET-28a lysate (as
the negative control) at the concentration of 0.002 mg/
mL in buffer bicarbonate (pH9.6) at 4°C overnight or
coated with the purified EMCV and BHK-21 cells’ pro-
tein at the concentration of 0.01 mg/mL as the same
way above. After washing with PBS containing 0.05%
Tween-80 (PBST) three times, the plates were blocked
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were incubated with the supernatant of hybridoma at 37°C
for 1 h. The sera isolated from immunized mice and the
supernatant of SP2/0 cells were used as positive and nega-
tive controls, respectively. After three washes with PBST,
wells were incubated with a 1:10,000 diluted goat anti-
mouse IgG-HRP at 37°C for 1 h. After washing, the plates
were incubated with substrate solution tetramethyl benzi-
dine (TMB) at 37°C for 10 min, and the reaction was
stopped with 2 M H2SO4 in each well (50 ml/well).The
OD was read at 450 nm in an automatic ELISA plate
reader. The criteria were judged as follows: the OD450 of
the positive control should be more than 1.0, the OD450 of
the negative controls should be lower than 0.2. The results
were expressed as the ratio of OD450 produced by the sam-
ples compared to the negative control. Samples, giving a
ratio value higher than 2.1, were considered to be positive.
For mapping the epitopes precisely, a series of trun-
cated fragments of protein were expressed in E.coli. The
epitopes recognized by McAbs were mapped by trun-
cated VP1 fragments based on indirect ELISA as de-
scribed above.Precise localization of epitopes
In order to identify the minimal antigenic epitopes recog-
nized by McAbs, the VP1 gene was divided into 26Figure 9 Schematic diagram of the VP1 protein, showing the express
interaction with McAbs in indirect ELISA analysis. “+”: Positive. “-”: Negatruncated fragments (Figure 9). A series of primers
(Table 1) were synthesized to amply the different truncated
fragments of VP1 protein. PCR products were separately
cloned into the Xho I and BamH I sites of pGEX-6p-1
expression vector. The recombinant proteins were
expressed in E.coli BL21 and identified by SDS-PAGE
and Western blot with the GST-tagged monoclonal
antibody (Boshide, Wuhan, China), and then were used
to determine the epitopes recognized by McAbs using
indirect ELISA and Western blot methods.
Western blot
To identify the proteins expressed in E. coli (VP1 and
truncated VP1 proteins), the proteins were separated by
SDS-PAGE (5-12%) and transferred to nitrocellulose
membrane (Pall Corporation). The McAbs (dilution of
1:10–1:50) bound to the proteins on the membrane was
detected by goat anti-mouse IgG-HRP (Boshide, Wuhan,
China) at 37°C for 1 h. Detection was performed using
chemiluminescenceluminol reagents (SuperSignal West
Pico Trial kit, PIERCE).
Indirect immunofluorescence assay (IFA)
BHK21 cells infected with EMCV NJ08 strain in 96-well
culture plate were rinsed with PBS and fixed with cold
ethanol for 45 min at 4°C. The cells were washed, andion constructs of the VP1 fragments F1 to F26 and their
tive.
Table 1 Primers set for amplification of the overlapping and truncated segments of VP1 gene
Fragment name Primer sequence (5′-3′) Fragment name Primer sequence (5′-3′)
F1:1 ~ 168aa 5′-GATGGATCCGGAGTAGAAAACGC-3′ F14:18 ~ 168aa 5′-AATGGATCCGACTTTGTGGCTCAACC-3′
5′-TAACTCGAGCTAGCCTTCTGAGAG-3′ 5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′
F2:106 ~ 277aa 5′-CGCGGATCCCTTAAATCCAAACAG-3′ F15:17 ~ 168aa 5′-TAAGGATCCGCTGACTTTGTGGC-3′
5′-GACCTCGAGTACTCTAGCATCAAG-3′ 5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′
F3:1 ~ 72aa 5′-GATGGATCCGGAGTAGAAAACGC-3′ F16:-100 ~ 23aa 5′-TTAGGATCCGGAGCGGGCAAG-3′
5′-CACCTCGAGCTAGTCAGTATCACTG-3′ 5′-ATCCTCGAGCTATGGTTGAGCCACAAA-3′
F4:38 ~ 105aa 5′-TAAGGATCCGATAGGTCCAGTC-3′ F17:-100 ~ 24aa 5′-TTAGGATCCGGAGCGGGCAAG-3′
5′-GACCTCGAGCTACGGAAAGACTTTTG-3′ 5′-CATCTCGAGCTAAACTGGTTGAGCCA-3′
F5:14 ~ 105aa 5′-ATTGGATCCGACGCAACTGCTGA-3′ F18:-100 ~ 25aa 5′-TTAGGATCCGGAGCGGGCAAG-3′
5′-GACCTCGAGCTACGGAAAGACTTTTG-3′ 5′-CATCTCGAGCTAGTAAACTGGTTGAGCC-3′
F6:7 ~ 105aa 5′-CAGGGATCCAAAGGGGTCACTGAAAAC-3′ F19:-100 ~ 26aa 5′-TTAGGATCCGGAGCGGGCAAG-3′
5′-GACCTCGAGCTACGGAAAGACTTTTG-3′ 5′-AGCCTCGAGCTACAAGTAAACTGGTTGA-3′
F7:4 ~ 168aa 5′-GCAGGATCCAACGCTGAAAAAG-3′ F20:43 ~ 168aa 5′-TAAGGATCCATTGGTGCCTTCACCG-3′
5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′ 5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′
F8:3 ~ 168aa 5′-CCGGGATCCGAAAACGCTGAAAAA-3′ F21:42 ~ 168aa 5′-ATTGGATCCCCCATTGGTGCCTTC-3′
5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′ 5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′
F9:2 ~ 168aa 5′-CGAGGATCCGTAGAAAACGCTGAA-3′ F22:41 ~ 168aa 5′-ATAGGATCCAGTCCCATTGGTGCC-3′
5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′ 5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′
F10:-100 ~ 6aa 5′-TTAGGATCCGGAGCGGGCAAG-3′ F23:-100 ~ 47aa 5′-TTAGGATCCGGAGCGGGCAAG-3′
5′-GCACTCGAGCTATTCAGCGTTTTCTACT-3′ 5′-TTCCTCGAGCTAGGTGAAGGCACCAAT-3′
F11:-100 ~ 7aa 5′-TTAGGATCCGGAGCGGGCAAG-3′ F24:-100 ~ 48aa 5′-TTAGGATCCGGAGCGGGCAAG-3′
5′-GGCCTCGAGCTATTTTTCAGCGTTTTCTAC-3′ 5′-ATACTCGAGCTACACGGTGAAGGCACC-3′
F12:20 ~ 168aa 5′-TCAGGATCCGTGGCTCAACCAGTTTAC-3′ F25:-100 ~ 49aa 5′-TTAGGATCCGGAGCGGGCAAG-3′
5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′ 5′-ATACTCGAGCTACTTCACGGTGAAGGC-3′
F13:19 ~ 168aa 5′-ACTGGATCCTTTGTGGCTCAACCAG-3′ F26:-100 ~ 50aa 5′-TTAGGATCCGGAGCGGGCAAG-3′
5′-ATTCTCGAGCTAGCCTTCTGAGAGGG-3′ 5′-AACCTCGAGCTAGGACTTCACGGTGAA-3′
Table 2 The EMCV reference strains cited in this study
Virus designation GenBank accession no Geographic origin Species Clinical field observation
GXLC FJ897755 China Swine Myocarditis
BJC3 DQ464062 China Swine Reproductive failure
HB1 DQ464063 China Swine Myocarditis
K3 EU780148 Korea Swine Reproductive failure
K11 EU780149 Korea Swine Reproductive failure
CBNU DQ517424 Korea Swine Reproductive failure
BEL-2887A AF356822 Belgium Swine Reproductive failure
PV21 X74312 Germany Swine Myocarditis
D variant M37588 USA Swine Myocarditis
EMC-B M22457 USA Swine Myocarditis
EMC-D M22458 USA Swine Myocarditis
GX0602 FJ604853 China Mice Myocarditis
Mengo-M L22089 Uganda Monkey Myocarditis
Mengo Rz-pMwt DQ294633 USA Myocarditis
EMCV-R M81861 USA Chimpanzee Myocarditis
PEC9 DQ288856 USA Mice Myocarditis
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for 1 h at 37°C. After washing with PBST, the cells were
incubated with goat anti-mouse IgG conjugated with
fluorescein (1:50 diluted in PBST) for 30 min at 37°C.
After rinsing by five times, cells were kept in PBS and
observed under a ZEISS fluorescence microscope.
Peptide-based ELISA
Three linear epitopes (P2-7aa, P19-25aa and 42-49aa)
identified in this study were synthesized using Fmoc solid-
phase chemistry (Invitrogen) with >98% purity. They were
coated in Reacti-Bind™ Amine-binding, Maleic Anhydride
96-well plates (Pierce, U.S.A.) at the concentration of
10ug/ml for 5 h at room temperature. Meanwhile, purified
GST-1-72aa (F3) and rVP1 protein were used as positive
antigens control. Mice anti-EMCV serum (at dilution of
1:100) were added as the primary antibody and incubated
at 37°C for 1 h. The SPF mice serum was used as negative
antibody control. The following detection steps were the
same as described above.
Alignment of VP1 epitopes sequences
Nucleotide sequences of EMCV strains from different
countries were retrieved from Genbank. The amino acid
sequences of identified B-cell epitopes were aligned
using DNAstar MegAligen software. The representative
EMCV strains were listed in Table 2.
3D model analysis of these epitopes
Molecular graphics and analyses were performed with
the UCSF Chimera package. Chimera is developed by
the Resource for Biocomputing, Visualization, and In-
formatics at the University of California, San Francisco
(supported by NIGMS P41-GM103311).
Statistics
The differences in the level of antibodies between differ-
ent groups were determined by One-way repeated meas-
urement ANOVA and Least significance difference
(LSD). Differences were considered statistically signifi-
cant when p < 0.05.
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